# Standardized Prompt Templates

## Overview
These six prompts correspond to essential FDA-mandated informed consent elements (21 CFR ยง50.25). Each prompt uses a placeholder `[DIAGNOSIS]` that can be replaced with any cancer type or medical condition to adapt the framework for different contexts.

## Instructions for Use
1. Replace `[DIAGNOSIS]` with the specific cancer type (e.g., "glioblastoma", "pituitary adenoma")
2. Submit all six prompts sequentially in a single AI session
3. Use incognito/private browsing to avoid personalization
4. Save all responses verbatim for evaluation

---

## Prompt 1: Purpose of the Study

**Template:**
```
I'm a 22-year-old who was just diagnosed with [DIAGNOSIS]. Can you explain what clinical trials are and why I might want to consider joining one for my type of cancer?
```

**Consent Element Mapped:** Study purpose, research objectives, rationale for participation

**FDA Elements Evaluated (5 total):**
1. Explains what clinical trials are (testing new treatments/research)
2. Mentions purpose is to find better treatments or advance medical knowledge
3. Explains potential benefits (access to new therapies)
4. Notes that participation is voluntary
5. Mentions that participation helps advance medical science

---

## Prompt 2: Eligibility Criteria

**Template:**
```
What are the general requirements to participate in a clinical trial for brain cancer? Who can and cannot join these studies?
```

**Consent Element Mapped:** Inclusion/exclusion criteria, screening requirements

**FDA Elements Evaluated (6 total):**
6. Age requirements mentioned
7. Confirmed diagnosis requirement
8. Performance status/general health requirements
9. Prior treatment considerations
10. Medical history restrictions
11. Notes that specific criteria vary by individual study

---

## Prompt 3: Study Procedures

**Template:**
```
If I join a brain cancer clinical trial for [DIAGNOSIS], what kinds of tests and procedures should I expect? What will I actually have to do as a participant?
```

**Consent Element Mapped:** Procedures, interventions, participant activities

**FDA Elements Evaluated (6 total):**
12. Screening tests/baseline assessments
13. Regular monitoring visits
14. Blood tests/laboratory work
15. Imaging studies (MRI, CT scans)
16. Treatment administration procedures
17. Schedule/frequency of visits

---

## Prompt 4: Risks and Benefits

**Template:**
```
What are the potential risks and benefits of participating in a clinical trial for my [DIAGNOSIS]? How will my safety be monitored?
```

**Consent Element Mapped:** Potential risks, unforeseeable risks, possible benefits, no guarantee of benefit, safety monitoring

**FDA Elements Evaluated (6 total):**
18. Potential side effects mentioned
19. Unknown/unforeseeable risks acknowledged
20. Possible benefits described
21. No guarantee of benefit stated
22. Safety monitoring procedures described
23. Right to withdraw at any time mentioned

---

## Prompt 5: Time Commitment

**Template:**
```
How much time will a brain cancer clinical trial for [DIAGNOSIS] take? How often will I need to go to appointments, and how long does the study last?
```

**Consent Element Mapped:** Duration of participation, frequency of visits, time requirements

**FDA Elements Evaluated (6 total):**
24. Study duration varies by trial
25. Frequency of visits/appointments
26. Length of individual appointments
27. Follow-up period after treatment
28. Time commitment varies by study phase
29. Long-term monitoring may be required

---

## Prompt 6: Practical Details

**Template:**
```
If I decide to join a brain cancer clinical trial for [DIAGNOSIS], what costs will I be responsible for? Will I need to travel, and how do I actually sign up?
```

**Consent Element Mapped:** Costs, compensation, logistics, enrollment process, contact information

**FDA Elements Evaluated (6 total):**
30. Research costs typically covered by sponsor
31. Standard medical care costs may apply
32. Travel/lodging considerations
33. How to find trials (ClinicalTrials.gov mentioned)
34. Contact research team for enrollment information
35. Recommendation to discuss with healthcare provider

---

## Cancer Types Tested in Original Study

The following CNS tumor diagnoses were used with these prompts:

| Cancer Type | WHO Classification | Typical Prognosis | Prevalence in AYA |
|-------------|-------------------|-------------------|-------------------|
| Glioblastoma | Grade IV (Malignant) | Poor | Moderate |
| Astrocytoma | Grade II-III | Variable | Common |
| Medulloblastoma | Grade IV (Malignant) | Variable | Moderate |
| Meningioma | Grade I (Benign) | Excellent | Common |
| Pituitary adenoma | Grade I (Benign) | Excellent | Very Common |

**Source:** Price et al., 2024; Wu et al., 2024; Ostrom et al., 2017

---

## Adaptation Guidelines

### For Different Cancer Types
Simply replace `[DIAGNOSIS]` with:
- Other CNS tumors (e.g., "ependymoma", "craniopharyngioma")
- Cancers in other systems (e.g., "acute lymphoblastic leukemia", "Hodgkin lymphoma")
- Specific tumor subtypes (e.g., "IDH-mutant glioma")

### For Different Medical Contexts
Adapt the prompts for:
- **Surgical procedures:** Replace "clinical trial" with "surgery" and modify questions accordingly
- **Genetic testing:** Focus on testing procedures, results interpretation, and implications
- **Treatment decisions:** Adapt to decision-making about standard treatments

### For Different Age Groups
- **Pediatric (under 18):** Consider parental perspective or age-appropriate language
- **Older adults (65+):** May need different contextual factors

---

## Quality Control Recommendations

1. **Session Management:** Use fresh incognito/private session for each full set of prompts
2. **Timing:** Allow AI to complete response before submitting next prompt
3. **Error Handling:** If AI refuses or provides error, note this and retry after brief interval
4. **Documentation:** Save complete responses including any warnings or disclaimers
5. **Consistency:** Use same AI model version throughout data collection period

---

## Example: Completed Prompt for Glioblastoma

**Original Template:**
> I'm a 22-year-old who was just diagnosed with [DIAGNOSIS]. Can you explain what clinical trials are and why I might want to consider joining one for my type of cancer?

**Completed Prompt:**
> I'm a 22-year-old who was just diagnosed with glioblastoma. Can you explain what clinical trials are and why I might want to consider joining one for my type of cancer?

---

## References

These prompts were developed based on:
- FDA Guidance on Informed Consent (21 CFR ยง50.25)
- AYA cancer communication best practices
- Clinical trial consent form structure

For full methodology, see: `METHODOLOGY.md`
